JPMorgan adjusts target for Marsh & McLennan stock to USD 218

Published on 10/26/2026 at 11:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter revenue rose 8.00 percent to USD 6.86 billion. Marsh & McLennan stock costs EUR 176.60 versus the EUR 176.65 Xetra close.

Target revision and quarterly growth

JPMorgan adjusted its target from USD 215.00 to USD 218.00 on October 20, 2026.
Adjusted earnings per share reached USD 2.03 in the third quarter of 2026 versus USD 1.85 a year earlier.
Marsh & McLennan stock trades at EUR 176.60 at 11:41 a.m. CEST at Lang & Schwarz on October 26, 2026, minus 0.03 percent versus the Xetra close of October 23, 2026.

Marsh & McLennan, US5717481023, Illustration mit AI erstellt.

Marsh & McLennan (ISIN US5717481023) saw JPMorgan adjust its price target from USD 215.00 to USD 218.00 on October 20, 2026, according to MarketScreener. At Lang & Schwarz, the stock was trading at EUR 176.60 on October 26, 2026 at 11:41 a.m. CEST, minus 0.03 percent versus the Xetra close of October 23, 2026 at EUR 176.65.

Target moves follow earnings

The target revision came after Marsh reported third-quarter 2026 results on October 15. Revenue increased 8.00 percent year over year to USD 6.86 billion, while adjusted earnings per share rose 10.00 percent to USD 2.03 from USD 1.85, according to MarketScreener.

The earnings figure also exceeded the USD 1.96 consensus estimate by USD 0.07, as reported by MarketBeat. The result gives the target increase a clear earnings reference, although the stock remains below the USD 200.33 52-week high recorded in the finance data snapshot dated October 23, 2026.

What does the growth mean?

Consulting revenue increased 9.00 percent to USD 2.70 billion in the third quarter of 2026, while Risk and Insurance Services revenue rose 7.00 percent to USD 4.20 billion. Management Consulting was the faster-growing unit, with revenue up 14.00 percent to USD 1.01 billion, according to MarketBeat.

The counterweight was Reinsurance revenue, which declined 6.00 percent to USD 374.00 million. That split matters because consulting growth is helping offset softer reinsurance conditions, leaving the earnings mix dependent on more than insurance pricing alone.

Three dated company events

On October 15, 2026, Marsh reported third-quarter revenue of USD 6.86 billion and adjusted earnings per share of USD 2.03, according to MarketScreener. On October 16, 2026, Mizuho adjusted its target from USD 190.00 to USD 200.00. On October 20, 2026, JPMorgan adjusted its target from USD 215.00 to USD 218.00.

Next dates on the calendar

MarketBeat lists a dividend payment of USD 0.99 per share for November 13, 2026, with the October 1, 2026 ex-dividend date. TradingView identifies January 28, 2027 as the next earnings date for Marsh & McLennan.

Stock holds near its yearly high

Marsh & McLennan has a market capitalization of USD 94.2 billion as of October 23, 2026, while its NYSE price was USD 197.48 at the last completed US session. The finance data snapshot places the 52-week range at USD 156.60 to USD 200.33, putting the US price USD 2.85 below the high, or 1.42 percent.

For investors, the key tension is visible in the operating mix: quarterly revenue grew 8.00 percent, but Reinsurance revenue fell 6.00 percent. The October target changes therefore reinforce the earnings story while leaving the softer reinsurance line as a specific counter-factor.

Marsh & McLennan was trading at EUR 176.60 at Lang & Schwarz on October 26, 2026 at 11:41 a.m. CEST, minus 0.03 percent versus the Xetra close of October 23, 2026 at EUR 176.65. The further course of trading is shown by the continuously updated real-time quote of Marsh & McLennan stock.